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Background 
There is little evidence that lung cancer screening prompts smoking cessation in screened 
populations overall. However, a more complex relationship is emerging where abnormal screening 
results appear to promote abstinence and those smokers who attend screening seem more 
motivated to stop smoking than those who do not. There is a need to understand how screening 
programmes can best facilitate reductions in smoking prevalence in screening populations. We 
aimed to investigate in the context of lung cancer screening i) facilitators to smoking cessation and 
continued abstinence and ii) attitudes to cessation support. 
Methods 
A qualitative sub-study to the Early Cancer detection test Lung cancer Scotland (ECLS) trial was 
conducted. We examined responses to ECLS questionnaires completed pre- and post-screening to 
sample smokers who had made a successful attempt to stop smoking, an unsuccessful attempt to 
stop or no attempt to stop since screening. Participants with positive and negative screening test 
results were sampled. Thirty-one in-depth semi-structured face-to-face interviews were conducted 
to investigate wider experiences of smoking in the screening context. Audio recordings were 
transcribed verbatim and thematically analysed. We present here a subset of data relating to the 
specific aims above. 
Results 
Participants reported receiving a 'fright' from positive test results and reassurance from negative 
results, both facilitating smoking cessation. Test results were seen as objective health feedback 
which could not be ignored. Recipients of positive test results were further motivated to remain 
abstinent by the prospect of future study-related CT scans. There was evidence that some had 
participated in screening with the intention of stopping smoking. Screening factors often acted in 
combination with other facilitators, including increasing smoking stigma, and life-stage changes such 
as becoming a grandparent. Attitudes to cessation support combined with a screening programme 
were mixed. Some felt they would be deterred from attending screening if they thought they would 
be targeted with cessation messages. Others were open to the idea of cessation support but 
doubted whether it could offer cessation strategies they had not already tried. 
Conclusion 
Smoking cessation support targeted at lung cancer screening groups should take into account ways 
that test results can facilitate cessation attempts, and the contributing social and life stage factors of 
older smokers. Some smokers eligible for screening may be deterred by the prospect of associated 
cessation interventions. Others who want to quit may have exhausted available cessation strategies 
and may be seeking something novel to help them quit. 
